Neuronetics(STIM)
MALVERN, PAMedical Devices
Focus: Neuronetics is a publicly traded medical device company specializing in Transcranial Magnetic Stimulation (TMS) therapy for psychiatric and neurological disorders, with 5,000+ employees and revenue of $71M.
Profile data last refreshed 16m ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
5000+
Open Jobs
41-3 this month
Stable — net -3 jobs in 30d
25 added, 28 removed. Backfill posture.
Should You Work at Neuronetics?
AI assessmentGood fit for supply chain, operations, and clinical specialists seeking stability; risky for R&D-focused roles given constrained innovation spending and persistent losses.
Why Work Here
- Established public company (ticker: STIM) with stable revenue base of $71M and $60M cash reserves providing job security.
- Significant hiring momentum in supply chain (29 roles) and clinical services (6 roles) indicates expansion into manufacturing and patient support infrastructure.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$71M
Pipeline & Clinical Trials
repetitive Transcranial Magnetic Stimulation
Major Depressive DisorderClinical Trials (1)
NCT05535062Study to Evaluate Treatment Effects Associated With the NeuroStar SoftStart Treatment Feature
N/AHelp build intelligence for Neuronetics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.